Breaking News, Financial News

Financial Report: Allergan 1Q

Specialty pharmaceutical sales increased 10% to $907.3 million in the quarter.

Allergan 1Q

1Q Revenues:
$1.1 billion (+11%)

1Q Earnings:
$169.0 million (earnings were $45.0 million in 1Q09)

Comments: Specialty pharmaceutical sales increased 10% to $907.3 million in the quarter. Top sellers, Restasis and the Lumigan Franchise, achieved growth of 23% and 18%, respectively. Restasis sales totaled $133.4 million and Lumigan sales were $119.6 million. Total medical device sales were up 18% percent to $198.5 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters